EMAIL DETAILS

He should have gone through me. Emailing the co founder (Brett) is not the proper protocol, nor is sending an unsolicited email that's 5MB when they have a "research inbox" for things like this.

Begin forwarded message:

> From: John DeLoche <john@rstp.com>
> Date: January 20, 2015 at 5:54:01 PM EST
> To: bbarth@bbrpartners.com, Todd Whitenack <TWhitenack@bbrpartners.com>, William Page <wpage@bbrpartners.com>
> Cc: Dan McHale <dmchale@rspinv.com>, Will Lee <will@rstp.com>, Neil Callahan <neil@rstp.com>, "devon@rstp.com" <devon@rstp.com>
> Subject: RSTP Growth Equity Update
>
> Brett, Todd and Will,
>
> Happy New Year from the RSTP Team! Lots of good news to share as RSTP finished an active 2014 by leading the first institutional investment round in Metabiota, a profitable software and services company that is the world leader in capturing, analyzing, preventing and insuring against microbial threats. Attached is recent Metabiota press from Wall Street Journal: http://www.rstp.com/nathan-wolfe-hunt-new-viruses/
>
> More portfolio company news with Counsyl, a company completely disrupting the Lab Testing market through software and robotics, had a record year with both number of completed tests and revenue. They are on target and now in the process of preparing for an IPO. Attached is recent Counsyl press from the Wall Street Journal:http://www.rstp.com/counsyl-new-genetic-tests/
>
> RSTP will hold rolling closings in the coming months as we move toward our final June closing of RSTP II, LP. We will be calling to schedule a time to follow up with you to discuss our portfolio, pipeline and a partnership between our firms over dinner or a meeting. Attached is our updated RSTP Overview Presentation.
>
> Best regards,
>
> The RSTP Team
>
> John, Will, Neil and Devon
>
> John DeLoche
> Co-founder & Managing Director
> RSTP
> 333 Bush Street, 21st Floor
> San Francisco, CA 94104
> direct: 415 767 1288
> mobile: 415 793 7070
>
>
> <Confidential RSTP Overview.pdf